Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:2860-2865

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pandozi, C.
Right arrow Articles by Santini, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pandozi, C.
Right arrow Articles by Santini, M.

(Circulation. 1998;98:2860-2865.)
© 1998 American Heart Association, Inc.


Clinical Investigation and Reports*

Electrophysiological Characteristics of the Human Atria After Cardioversion of Persistent Atrial Fibrillation

Claudio Pandozi, MD; Leopoldo Bianconi, MD; Mauro Villani, MD; Giuseppe Gentilucci, MD; Antonio Castro, MD; Giuliano Altamura, MD; Anna P. Jesi, MD; Filippo Lamberti, MD; Fabrizio Ammirati, MD; Massimo Santini, MD

From the Department of Cardiology, San Filippo Neri Hospital, Arrhythmia Control Unit (M.V.), La Sapienza University, Rome, Italy.

Correspondence to Claudio Pandozi, MD, Via Madonna di Fatima, 22, 00147, Rome, Italy. E-mail mvillani{at}uniroma1.it

Background—In animal models, induced atrial fibrillation shortens the atrial effective refractory period (ERP) and reverses its physiological adaptation to rate. It is not clear whether this process, known as "electrical remodeling," occurs in humans.

Methods and Results—We determined the ERPs, at 5 pacing cycle lengths (300 to 700 ms) and in 5 right atrial sites, after internal cardioversion of chronic atrial fibrillation in 25 patients (14 in pharmacological washout and 11 on amiodarone). The ERPs were 195.5±18.8 ms in the washout and 206.3±17.9 ms in the amiodarone patients (P<0.0001). ERPs were closely correlated with the stimulation rates (r=0.95 in the washout and r=0.94 in the amiodarone group), and slope values indicating a normal (>=0.07) or nearly normal (0.05 to 0.06) adaptation of ERP to rate were found in 77% of the 84 paced sites. The mean ERP was shorter in the lateral wall (198.1±17.9 ms) than in the atrial roof (203.3±21.5 ms) and in the septum (210.5±20.0 ms) (P<0.03). After 4 weeks of sinus rhythm, the mean ERP, determined again in 8 patients (4 in wash-out and 4 on amiodarone), was significantly increased compared with the basal study (221.4±21.4 versus 197.8±18.3 ms, P<0.0001).

Conclusions—After cardioversion of chronic atrial fibrillation, (1) atrial ERP adaptation to rate was normal or nearly normal in the majority of the cases, (2) a significant dispersion of refractoriness between different right atrial sites was present, and (3) ERPs were significantly increased after 4 weeks of sinus rhythm in both washout and amiodarone patients.


Key Words: fibrillation • remodeling • electrophysiology • atrium




This article has been cited by other articles:


Home page
EuropaceHome page
P. Spurrell, K. Kamalvand, M. Higson, and N. Sulke
Temporal changes in atrial refractoriness following DC cardioversion of persistent atrial fibrillation in man
Europace, January 1, 2004; 6(3): 229 - 235.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
G.L. Botto, M. Luzi, and A. Sagone
Atrial fibrillation: the remodelling phenomenon
Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H1 - H7.
[Abstract] [PDF]


Home page
HeartHome page
V. Markides and R. J Schilling
Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment
Heart, August 1, 2003; 89(8): 939 - 943.
[Full Text] [PDF]


Home page
EuropaceHome page
I. Savelieva and A. John Camm
Atrial fibrillation and heart failure: natural history and pharmacological treatment
Europace, January 1, 2003; 5(s1): S5 - S19.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H.-F. Tse and C.-P. Lau
Electrophysiologic actions of dl-sotalolin patients with persistent atrial fibrillation
J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2150 - 2155.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. P. Fynn and C. J. Garratt
The effectiveness of serial cardioversion therapy for recurrence of atrial fibrillation
Eur. Heart J., October 1, 2002; 23(19): 1487 - 1489.
[Full Text] [PDF]


Home page
Eur Heart JHome page
R. Ricci, C. Pignalberi, M. Disertori, A. Capucci, L. Padeletti, G. Botto, S. Toscano, F. Miraglia, A. Grammatico, and M. Santini
Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias
Eur. Heart J., September 2, 2002; 23(18): 1471 - 1479.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Fan, K. L. Lee, W.-H. Chow, E. Chau, and C.-P. Lau
Internal Cardioversion of Chronic Atrial Fibrillation During Percutaneous Mitral Commissurotomy: Insight Into Reversal of Chronic Stretch-Induced Atrial Remodeling
Circulation, June 11, 2002; 105(23): 2746 - 2752.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M. Brundel, R. H. Henning, H. H. Kampinga, I. C. Van Gelder, and H. J.G.M. Crijns
Molecular mechanisms of remodeling in human atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 315 - 324.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Kurita, H. Mitamura, A. Shiroshita-Takeshita, A. Yamane, M. Ieda, O. Kinebuchi, T. Sato, S. Miyoshi, M. Hara, S. Takatsuki, et al.
Daily oral verapamil before but not after rapid atrial excitation prevents electrical remodeling
Cardiovasc Res, May 1, 2002; 54(2): 447 - 455.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B.-S. Kim, Y.-H. Kim, G.-S. Hwang, H.-N. Pak, S. C. Lee, W. J. Shim, D. J. Oh, and Y. M. Ro
Action potential duration restitution kinetics in human atrial fibrillation
J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1329 - 1336.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Korte, M. Niehaus, G. Borchert, and J. Tebbenjohanns
Significant prolongation of atrial monophasic action potential duration: short-term reverse electrophysiological changes after internal cardioversion of atrial fibrillation
Cardiovasc Res, March 1, 2002; 53(4): 944 - 951.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.P Fynn, D.M Todd, W.J.C Hobbs, K.L Armstrong, and C.J Garratt
Role of dispersion of atrial refractoriness in the recurrence of clinical atrial fibrillation. A manifestation of atrial electrical remodelling in humans?
Eur. Heart J., October 1, 2001; 22(19): 1822 - 1834.
[Abstract] [PDF]


Home page
HeartHome page
E. BERTAGLIA, D. D'ESTE, A. ZANOCCO, F. ZERBO, and P. PASCOTTO
Effects of pretreatment with verapamil on early recurrences after electrical cardioversion of persistent atrial fibrillation: a randomised study
Heart, May 1, 2001; 85(5): 578 - 580.
[Full Text]


Home page
Eur Heart JHome page
C Pandozi and M Santini
Update on atrial remodelling owing to rate. Does atrial fibrillation always 'beget' atrial fibrillation?
Eur. Heart J., April 1, 2001; 22(7): 541 - 553.
[PDF]


Home page
J Am Coll CardiolHome page
B. J. J. M. Brundel, I. C. Van Gelder, R. H. Henning, A. E. Tuinenburg, M. Wietses, J. G. Grandjean, A. A. M. Wilde, W. H. Van Gilst, and H. J. G. M. Crijns
Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels
J. Am. Coll. Cardiol., March 1, 2001; 37(3): 926 - 932.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Gaita, L. Calo, R. Riccardi, L. Garberoglio, M. Scaglione, G. Licciardello, L. Coda, P. Di Donna, M. Bocchiardo, D. Caponi, et al.
Different patterns of atrial activation in idiopathic atrial fibrillation: simultaneous multisite atrial mapping in patients with paroxysmal and chronic atrial fibrillation
J. Am. Coll. Cardiol., February 1, 2001; 37(2): 534 - 541.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Pandozi, L. Bianconi, L. Calo, A. Castro, F. Lamberti, M. C. Scianaro, G. Gentilucci, and M. Santini
Postcardioversion atrial electrophysiologic changes induced by oral verapamil in patients with persistent atrial fibrillation
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2234 - 2241.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. B. Sparks, S. Jayaprakash, J. K. Vohra, and J. M. Kalman
Electrical Remodeling of the Atria Associated With Paroxysmal and Chronic Atrial Flutter
Circulation, October 10, 2000; 102(15): 1807 - 1813.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. G. Manios, E. M. Kanoupakis, G. I. Chlouverakis, M. D. Kaleboubas, H. E. Mavrakis, and P. E. Vardas
Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: relation with recurrence
Cardiovasc Res, August 1, 2000; 47(2): 244 - 253.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. B. Sparks, H. G. Mond, J. K. Vohra, S. Jayaprakash, and J. M. Kalman
Electrical Remodeling of the Atria Following Loss of Atrioventricular Synchrony : A Long-Term Study in Humans
Circulation, November 2, 1999; 100(18): 1894 - 1900.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.B. Olsson
Chronic atrial fibrillation - what is wrong with the atrium?
Eur. Heart J., June 2, 1999; 20(12): 856 - 857.
[PDF]